Microbot Medical Inc. (MBOT) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Hingham, MA, United States. El CEO actual es Harel Gadot.
MBOT tiene fecha de IPO 1992-03-25, 20 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $110.74M.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
